Occurrence of Severe SARS-CoV-2 Infection in Fully Vaccinated Solid Organ Transplant Recipients
Article
[키워드] accelerate
affected
age
Antibody Response
Antibody titer
approved
BNT162b2
booster dose
Clinical outcome
Coronavirus 2019
Course
Diagnosis
excluded
expired
Follow-up
glomerular filtration rate
highlighting
Hospitalization
Hospitalized
humoral
implementation
infected patient
Infection
median
median time
Mild symptom
mRNA vaccines
mRNA1273
Patient
patient cohort
patients
polymerase chain
positive
recipient
recipients
SARS-CoV-2
SARS-CoV-2 disease
second dose
severe disease
Solid
solid organ transplant
SOT
tested
the disease
Transplant
vaccinate
vaccination
Vaccine
was measured
[DOI] 10.1016/j.transproceed.2021.12.012 PMC 바로가기
[DOI] 10.1016/j.transproceed.2021.12.012 PMC 바로가기